Keywords: bioinvent, losses, fall, sales, climb, swedish, drugmaker
BioInvent's losses fall 22% as sales climb 80%
Article | 26 February 2007
Swedish drugmaker BioInvent says this its losses for the full year 2006 were 108.8 million Swedish kronor ($15.4 million), down 22.2% on the 139.9 million ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
